Danaher (DHR)
(Real Time Quote from BATS)
$248.69 USD
+1.85 (0.75%)
Updated May 3, 2024 02:31 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DHR 248.69 +1.85(0.75%)
Will DHR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DHR
Markel (MKL) Q1 Earnings, Revenues Miss Estimates, Rise Y/Y
Honeywell (HON) Q1 Earnings Beat, Aerospace Sales Rise Y/Y
DHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y
Other News for DHR
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
B&G Foods (BGS) Gets a Hold from RBC Capital
Danaher call volume above normal and directionally bullish
Danaher Corp: An Exploration into Its Intrinsic Value
Analysts Think This 170% Dividend Grower Is “Old News.” They’re Wrong.